anti-virals Flashcards
moa of oseltamivir
inhibits influenze neuraminidase - decreases release of progeny viruses
moa of zanamivir
inhibits influenza neuraminidase - decreases release of progeny viruses
treatment of influenza A and B
oseltamivir
zanamivir
MIVIRs
prevention of influenza A and B
oseltamivir
zanamivir
MIVIRs
MOA of acyclovir/famciclovir, valacyclovir
guanosine analougs
monoPi by HSV/VZV thymidine kinase and not uninfected cells
triphosphate by host enzymes
inhibits viral DNA polymerase by chain termination
treatment of HSV and VZV
acyclovir, famciclovir, valacyclovir
what virsus foes acyclovir, famiciclovir and valacyclovir work against?
HSV, VZV, weak against EBV
NO CMV
treatment of HSV induced mucocutanoeus and genital lesiosn
acyclovir
famiciclovir
valacyclovir
treatment of HSV encephalitis
acyclovir
famiciclovir
valacyclovir
use of acyclovir in immunosuppressed indvls
prhophylaxis
doc at herpes zoster
famiciclovir
toxo of acyclovir
obstructive crystalline nephropathy
acute renal failure
how do prevent toxo of acyclovir
hydration to prevent obstructive crystalline nephropathy/acute renal failure
how do HSV and VZV resists acyclovir
muta viral thymidine kinase
moa fo ganciclovir
5’monophosphate formed by a CMV viral kinase
guanosine analog
triphosphate formed by cellular kinases
inhibits viral DNA polymerase by chain termination
doc of CMV, especially in immunocmopromised
ganciclovir
toxos of ganciclovir
leukopenia
neutropenia
thrombocytopenia
renal toxicity
which is more toxic to host cells, acyclovir of ganciclovir
ganvivclovir - leuko/neutron/thrombocytopenia
moa of resistane of ganciclovir
mutated viral kinase
moa of foscarnet
viral DNA/RNA polymerase inhibitor and HIV reverse transcriptase inhibitor
binds to pyroFOSphaste binding site
NO ACTIVATION BY KINASE REQUIRED
what is foscarnet used for
CMV retinitins when ganciclovr doesn’t work
acyclovir resistant HSV
toxo of foscarnet please
nephrotoxicity
electrolyte abnormalities: hypo/hyperCa AND hypo/hyperPO4 and hypoK and hypoMg
electorylte abnormalities can lead to seizures
MOA resistance foscarnet
mutated DNA plymerase
MOA cidofovir
preferentially inhibits viral DNA polymerase
DOES NTO REQUIRE PHOS BY KINASE